The cardiologic prevention of stroke: current state of problem


Cite item

Full Text

Abstract

The stroke is one of the most significant medical social problems of the present time. The prevention of thromboembolism complications under cardiac fibrillation becomes a real mode of struggling with stroke. The formation of registries is often used as an instrument of evidence based medicine in this area. The article presents short review of recent studies in this field. The one's own original results are presented too: retrospective analysis of patient records and out-patient medical records of 1610 patients with fibrillation of atriums.

About the authors

Aleksandr V. Melekhov

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

Email: avmelekhov@gmail.com
MD, PhD 117997, Moscow, Russia

G. E Gendlin

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

кафедра госпитальной терапии № 2 лечебного факультета 117997, Moscow, Russia

E. M Alekseeva

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

кафедра госпитальной терапии № 2 лечебного факультета 117997, Moscow, Russia

E. F Dadashova

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

кафедра госпитальной терапии № 2 лечебного факультета 117997, Moscow, Russia

G. I Storozhakov

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

кафедра госпитальной терапии № 2 лечебного факультета 117997, Moscow, Russia

O. V Sertakova

The municipal clinical hospital N 24

Moscow, Russia

I. I Zakharova

The municipal clinical hospital N 24

Moscow, Russia

References

  1. ВОЗ. 10 ведущих причин смерти в мире. Информационный бюллетень № 310 Май 2014 г. Available at: http://www.who.int/mediacentre/factsheets/fs310/ru/
  2. Бойцов С.А. Профилактика неинфекционных заболеваний в стране: от «что делать» к «как делать». Профилактическая медицина. 2012; 15(2): 3-10.
  3. Суслина З.А., Верещагин Н.В., Пирадов М.А. Подтипы ишемических нарушений мозгового кровообращения: диагностика и лечение. Consilium Medicum. 2001; 3(5): 218-21.
  4. Сулимов В.А. Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА и АССХ, 2012. Российский кардиологический журнал. 2013; 4 S3(102): 1-100.
  5. Alam M., Bandeali S.J., Shahzad S.A., Lakkis N. Real-life global survey evaluating patients with atrial fibrillation (REALISE-AF): results of an international observational registry. Expert Rev. Car diovasc. Ther. 2012; 10(3): 283-91.
  6. Camm A.J., Breithardt G., Crijns H., Dorian P., Kowey P., Le Heuzey J.Y. et al. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Re gistry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J. Am. Coll. Cardiol. 2011; 58(5): 493-501.
  7. Nabauer M., Gerth A., Kirchhof P., Goette A., Limbourg T., Sprenger C. et al. Registry and studies of the German Competence Network on Atrial Fibrillation (AFNET). Herzschrittmacherther Elektrophysiol. 2010; 21(3): 153-9.
  8. Lara-Vaca S., Cordero-Cabra A., Martínez-Flores E., Iturralde-Torres P. The Mexican Registry of Atrial Fibrillation (ReMeFa). Gac. Med. Mex. 2014; 150 (Suppl. 1): 48-59.
  9. Andrade A.A., Li J., Radford M.J., Nilasena D.S., Gage B.F. Clinical Benefi t of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation. J. Gen. Intern. Med. 2015; 30(6): 777-82.
  10. Friberg L., Skeppholm M., Terént A. Benefi t of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J. Am. Coll. Cardiol. 2015; 65(3): 225-32.
  11. Chao T.F., Liu C.J., Wang K.L., Lin Y.J., Chang S.L., Lo L.W. et al. Should atrial fi brillation patients with 1 additional risk factor of the CHA2DS2-Vasc score (beyond sex) receive oral anticoagulation? J. Am. Coll. Cardiol. 2015; 65(7): 635-42.
  12. Olesen J.B., Lip G.Y., Hansen M.L., Hansen P.R., Tolstrup J.S., Lindhardsen J. et al. Validation of risk stratifi cation schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011; 342: d124.

Copyright (c) 2015 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies